Clinical Trial Detail

NCT ID NCT03197506
Title Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

gliosarcoma

glioblastoma multiforme

Therapies

Pembrolizumab + Temozolomide

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.